Announcement no. 20/2008
To NASDAQ OMX Copenhagen Copenhagen,
December 10, 2008
Voting Proxies issued to the Board of Directors
In accordance with Section 29 of the Danish Securities Trading Act, cf. Sections
4, no. 8 and 5, subsection 3 of Executive Order No. 1225 of 22 October 2007,
Curalogic A/S hereby announces that the Board of Directors has received proxies
from a number of shareholders authorising the Board of Directors of Curalogic
A/S to vote on their behalf at the Extraordinary General Meeting on December 11,
2008. On December 8, 2008 the Board of Directors of Curalogic A/S recieved
voting proxies resulting in the Board of Directors being authorised to vote on
shares corresponding to more than 5 per cent of Curalogic A/S' total aggregate
voting rights. As of this date the Board of Directors thus controls voting
rights which in aggregate amounts to 6.2 per cent of Curalogic A/S' share
capital and voting rights.
On December 11, 2008 after the Extraordinary General Meeting, the authorisation
of the Board of Directors to vote according to the voting proxies
will terminate. Standard notification form according to Executive Order No. 1225
of 22 October 2007 is attached to this announcement.
Yours faithfully,
Curalogic A/S
For additional information, please contact:
Jakob Schmidt, Chairman Tel. +45 20 22 68 60
Helle Busck Fensvig, EVP and CFO Tel. +45 99 99 24 03
This announcement contains forward-looking statements regarding the Company's
future financial development and performance and other statements which are not
historical facts. Such statements are made on the basis of assumptions and
expectations which, to the best of the Company's knowledge and belief, are
reasonable, at this time, but may prove to be erroneous in the future.
